BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34488078)

  • 1. Gender differences in the prevalence of heroin and opioid analgesic misuse in the United States, 2015-2019.
    McHugh RK; Nguyen MD; Chartoff EH; Sugarman DE; Greenfield SF
    Drug Alcohol Depend; 2021 Oct; 227():108978. PubMed ID: 34488078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in trends for heroin use and nonmedical prescription opioid use, 2007-2014.
    Marsh JC; Park K; Lin YA; Bersamira C
    J Subst Abuse Treat; 2018 Apr; 87():79-85. PubMed ID: 29433788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial/ethnic differences in prescription opioid misuse and heroin use among a national sample, 1999-2018.
    Schuler MS; Schell TL; Wong EC
    Drug Alcohol Depend; 2021 Apr; 221():108588. PubMed ID: 33639569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/Ethnic Differences in Prevalence Trends for Heroin use and Non-Medical use of Prescription Opioids Among Entrants to Opioid Treatment Programs, 2005-2016.
    Pouget ER; Fong C; Rosenblum A
    Subst Use Misuse; 2018 Jan; 53(2):290-300. PubMed ID: 28854060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual minority disparities in opioid misuse, perceived heroin risk and heroin access among a national sample of US adults.
    Schuler MS; Dick AW; Stein BD
    Drug Alcohol Depend; 2019 Aug; 201():78-84. PubMed ID: 31200278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription painkiller misuse and the perceived risk of harm from using heroin.
    Kapadia SN; Bao Y
    Addict Behav; 2019 Jun; 93():141-145. PubMed ID: 30711666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual Orientation Disparities in Prescription Opioid Misuse Among U.S. Adults.
    Duncan DT; Zweig S; Hambrick HR; Palamar JJ
    Am J Prev Med; 2019 Jan; 56(1):17-26. PubMed ID: 30467089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey.
    Montiel Ishino FA; McNab PR; Gilreath T; Salmeron B; Williams F
    BMC Public Health; 2020 Nov; 20(1):1740. PubMed ID: 33208132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with heroin use among those reporting -prescription opioid misuse: Results from a nationally -representative sample.
    Thomas AT; Fields KG; Kaye AD; Urman RD
    J Opioid Manag; 2022; 18(3):243-255. PubMed ID: 35666481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Opioid Misuse Among Individuals Aged 12 to 21 Years in the US.
    Warren LK; Adams J; Bobashev G
    JAMA Netw Open; 2023 Jun; 6(6):e2316276. PubMed ID: 37261827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Past-year prevalence of prescription opioid misuse among those 11 to 30years of age in the United States: A systematic review and meta-analysis.
    Jordan AE; Blackburn NA; Des Jarlais DC; Hagan H
    J Subst Abuse Treat; 2017 Jun; 77():31-37. PubMed ID: 28476268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of prescription fentanyl misuse in the United States.
    Schepis TS; McCabe VV; Boyd CJ; McCabe SE
    Addict Behav; 2019 Sep; 96():89-93. PubMed ID: 31063940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in the prevalence of stimulant misuse in the United States: 2015-2019.
    McHugh RK; Korte FM; Bichon JA; Weiss RD
    Am J Addict; 2024 May; 33(3):283-289. PubMed ID: 37924248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of County-Level Opioid Dispensing Rates on Individual-Level Patterns of Prescription Opioid and Heroin Consumption: Evidence From National U.S. Data.
    Vuolo M; Kelly BC
    Am J Psychiatry; 2022 Apr; 179(4):305-311. PubMed ID: 34875874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumstances and contexts of heroin initiation following non-medical opioid analgesic use in New York City.
    Harocopos A; Allen B; Paone D
    Int J Drug Policy; 2016 Feb; 28():106-12. PubMed ID: 26818082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.
    Jones CM
    Drug Alcohol Depend; 2013 Sep; 132(1-2):95-100. PubMed ID: 23410617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016.
    Han BH; Sherman SE; Palamar JJ
    Prev Med; 2019 Apr; 121():94-98. PubMed ID: 30763631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender Differences in Prescription Opioid Misuse Among U.S. Black Adults.
    Nicholson HL; Vincent J
    Subst Use Misuse; 2019; 54(4):639-650. PubMed ID: 30541373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pills to Powder: A 17-Year Transition From Prescription Opioids to Heroin Among US Adolescents Followed Into Adulthood.
    McCabe SE; Boyd CJ; Evans-Polce RJ; McCabe VV; Schulenberg JE; Veliz PT
    J Addict Med; 2021 May-Jun 01; 15(3):241-244. PubMed ID: 32991383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription opioid misuse among U.S. Hispanics.
    Cano M
    Addict Behav; 2019 Nov; 98():106021. PubMed ID: 31306983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.